Our team

Kellie-Ann has over 30 years’ experience as a leader in public health and health promotion. She has a Masters in Health Sciences and was a senior lecturer in health promotion at LaTrobe University. She has held senior management roles in policy and program development in State Government, VicHealth, community health and the not-for-profit sector and until recently, was the Chief Executive Officer Vic/Tas at the National Heart Foundation of Australia.

Kellie has served on numerous boards, advisory groups, research institutes and Ministerial appointed committees including the Cabrini Research Institute and Dental Health Services Victoria, where she chaired the Community Advisory Committee for 7 years.

In 2008, Kellie co-founded the not-for-profit organisation Victoria Walks and has been the Chair since 2010.

Kellie has a passion to prevent rather than treat disease which has driven most of her career. She has also been a strong advocate for community engagement and the need for organisations and services to actively listen and respond to the ‘voices’ of consumers to ensure quality care and effectiveness.

In her spare time, she works on her mental and physical fitness, catching up with friends and family, going to the theatre and travelling.

Heather Renton is the founder and President of Syndromes Without a Name (SWAN) - Australia, an advocacy group for families with undiagnosed children. Heather is the mother of a 10-year-old who until recently remained undiagnosed.

Heather is a member of the Croxton School Council, and also runs the Croxton parent support group and fundraising group.

Margaret retired in 2016 following a distinguished career of more than 40 years at the forefront of genetic counselling and patient support.

Appointed senior social worker at the Victorian Clinical Genetics Services (VCGS) in 1974, Margaret began working with families of children with genetic conditions, principally in the Bone Dysplasia Clinic. Margaret recognised the important role of parent support groups; she facilitated the formation of many and served on various boards. In 1996, together with various genetic support groups, Margaret founded the Genetic Support Network of Victoria (GSNV).

Margaret was a member of the inaugural Board of the Human Genetics Society of Australasia (HGSA), which developed the first guidelines to establish the profession of genetic counselling in Australia, in 1989. She went on to be appointed founding Director of the Master of Genetic Counselling (University of Melbourne).

Margaret was awarded the inaugural University of Melbourne (Department of Paediatrics) prize for excellence in teaching in 2016, and an Order of Australia in 2018. Two awards have been established in Margaret’s name: a GSNV incentive award for new support groups, and an academic excellence award in the Master of Genetic Counselling course.

Dr Janney Wale has a PhD in pharmacology and post-doctoral experience in industry, university and research institute environments. Forced to rethink her priorities because of her own health issues, Janney became an active member of the  Consumer Network for the evidence-based organisation, The Cochrane Collaboration, and a health consumer voice both locally and nationally in Australia.

Janney is particularly interested in empowering consumers with the health information they need to inform their choices for the health of themselves and their families. As a consumer editor at Cochrane, Janney contributes to the development of plain language summaries of systematic reviews of best evidence, published in the Cochrane Library. She is also a member of HTAi and enabling consumers to have a voice in new health technologies and health policy.

Janney is a member of The Royal Melbourne Hospital Community Advisory Committee.

Christine is a board member of the Consumer's Health Forum, a member of the Medical Services Advisory Committee Evaluation Subcommittee and a practising sociologist.

Christine manages a longitudinal survey into the social impact of epilepsy in Australia. Christine has researched and published extensively on self-management in chronic diseases, as well as consumer participation in health services.

Christine is a board member of NPS MedicineWise and of the National Standing Committee on Quality for the Royal Australian College of General Practitioners (RACGP). Current activities include working with Centre for Stem Cells Systems at the University of Melbourne, the consumer perspective on multiple conditions and a Primary Health Network in Victoria.

Spase has a strong interest in social justice and has over 20 years’ experience concerned with how to improve marginalised communities’ access to, and engagement with, health and community services. He has a particular interest in evaluation.

Spase started in community engagement working for Migrant Resource Centres in Melbourne’s west. He has worked in mental health and community health in ethnic diversity, equity and inclusion roles.

Spase is an experienced project worker and trainer in organisational cultural competence, health literacy and language services at Centre for Culture, Ethnicity and Health.

Stacey is an experienced management consultant with over 15 years’ experience in both private, public and community sectors.

Stacey leads her own consulting practice - One Red Step - focusing on social policy and social justice. Stacey is a former Director with PricewaterhouseCoopers leading its social policy practice particularly on education, gender equality  and family violence. 

Stacey is a Board member of Safe and Equal and Melbourne City Mission and is a Finance and Risk Subcommittee member of Our Watch. She is an IPAA Women of Colour mentor and was PwC’s inaugural staff lead for its cultural diversity and inclusion network for three years enabling conversations about racism and inclusion with over 8,000 people. 

Sue’s interest in genetics, and health care started over 45 years ago when her youngest sister was diagnosed with cystic fibrosis (CF). This initial interest led her into the field of medical laboratory science in the areas of haematology and blood bank and she worked across a number of metropolitan Melbourne public hospitals.

Following the birth of her son (1994) with CF she moved into the field of information technology working across many different sectors, including government, health, education, and telecommunications in a variety of roles such as technical writing and training. At the same time, she stepped up her CF volunteer work, which includes peer support, public speaking, advocacy, and research fundraising.

Sue is an experienced healthcare consumer representative (HCR) with established community connections and networks. She is an active HCR member of Safer Care Victoria, Health Issues Centre and Eastern Health, which includes Community Advisory Committee experience and other initiatives to improve patient-centred care.

Sue is a past recipient of a Cystic Fibrosis Community Care award for her continued support and dedication to raising CF awareness, and a Victorian Premier’s Volunteer Champion teamwork award relating to the annual ‘65km for CF’ research fundraising event that she and four other CF mums organise.

Sue is very excited about the subject of genomics and its application in helping improve healthcare and is grateful for the opportunity to be a member of the Community Advisory Group.

Maya wears many hats but is first and foremost a mum to two beautiful children, Lloyd aged 6 and Elsie aged 3. Lloyd was diagnosed with ‘Iqsec2 Associated Disorder’ – a syndrome without a name in 2019. She is currently completing a Bachelor of Science (Honours) and owns a small business that sells adaptive clothing for children. She is a passionate advocate and volunteer who applies capacity building approaches at all levels, including through research, policy and beyond.

A lawyer and company director, Catherine is also the Chairperson of Financial Adviser Standards & Ethics Authority, a member of the Reserve Bank of Australia’s Payments System Board, a Director of Australian Foundation Investment Company and Trustee of the Helen Macpherson Smith Trust.

She is a former Chair of Federation Square Pty Ltd and the Australian Synchrotron Company Ltd, Deputy Chair of Victorian Funds Management Corporation and a Director of ASX, National Australia Bank Ltd, Orica Ltd and the Melbourne Business School.

Professor Shelley Dolan joined the RMH in August 2023 as Chief Executive. She is a familiar face in the Parkville Precinct, previously serving as the Chief Executive of the Peter MacCallum Cancer Centre.

Professor Dolan is a highly respected clinical and research leader with an impressive track record in health care, having successfully led major organisational and cultural change in Victoria and the United Kingdom (UK).

Key capabilities include executive and non-executive leadership across national and international bodies, strategy development, delivering excellence in quality and performance, overseeing large capital schemes and innovative research projects that require engagement with a broad range of stakeholders.

Bernadette McDonald was appointed to the role of CEO of The Royal Children’s Hospital (RCH) in September 2021.

Bernadette was previously the CEO of Canberra Health Services at a time of great change in the ACT’s health service system. Prior that appointment, she was the Deputy CEO and then Interim CEO of Austin Health, having previously been the CEO of the Orbost Regional Health Service.

Bernadette is a highly experienced leader with a track record of delivery in the Australian health sector. Known for her strategic vision, strong relationships, inspirational leadership and commitment to exceptional patient care, she demonstrates authentic leadership, and positions organisations for success by strategically assessing the environment and providing foresight to maximise impact and reputation.

Bernadette has a Bachelor of Nursing, a Masters of Health Administration, post graduate diplomas in Health Services and Health Systems Management, and is a Graduate of the Australian Institute of Company Directors.

Mike McGuckin is the Associate Dean Research in the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne. In this role he has strategic oversight of a broad spectrum of health research across this prestigious Faculty which is ranked =#11 internationally by the Times Higher Education Rankings.

He is a former NHMRC Principal Research Fellow and before taking up his current role was the Deputy Director (Research) of the Mater Research Institute – The University of Queensland within the Translational Research Institute in Brisbane, where he also led an Inflammatory Disease Biology and Therapeutics Research Group.

As Chief Operating Officer, Carolyn leads WEHI’s Professional Services team to collaborate with our scientists as we work to make medical research discoveries that help our community live longer, healthier lives. She leads a team of experienced executives who deliver WEHI’s Business Development, Communications and Marketing, Research Grants, Philanthropy, Bioservices and Laboratory Operations, Facilities, Governance, Risk and Compliance and Information Technology Services functions.

Professor Kathryn North AC is Director of the Murdoch Children's Research Institute and the David Danks Professor of Child Health Research at The University of Melbourne.

Professor North is trained as a physician, neurologist and clinical geneticist and, in 1994, was awarded a doctorate for research in neurogenetics. She completed a postdoctoral fellowship in the Harvard Genetics Program.

Professor North is a national and international leader in Genomic medicine. In 2014, Professor North was appointed as Co-Chair of the Global Alliance for Genomics and Health - a collaborative network of over 500 organisations across over 100 countries funded by the NIH and the Wellcome Trust (genomicsandhealth.org). Commencing in 2016, she leads an NHMRC-funded national network of over 80 institutions - the Australian Genomics Health Alliance (AGHA). 

Professor Brett Sutton is the Director of CSIRO's Health and Biosecurity business unit. A qualified public health physician, he has extensive experience and clinical expertise in public health and communicable diseases, gained through experience in Government, emergency medicine and field-based international work.

Most recently, Prof Sutton has held the role of Victoria’s Chief Health Officer together with the role of Victoria’s Chief Human Biosecurity Officer. Prior to his appointment as Chief Health Officer, Professor Sutton held several senior positions within the Victorian Department of Health, including as Deputy Chief Health Officer (Communicable Disease) and within their Health Protection Branch.

Professor Sutton also has specialist knowledge in tropical medicine and infectious disease, including in lower-middle income countries and complex humanitarian environments, and has worked in various specialised health roles in Afghanistan, Ethiopia, Kenya, Timor-Leste, and Fiji.

Professor Sutton is a Fellow of the Royal Society for Public Health, a Fellow of the Australasian College of Tropical Medicine, and a Fellow of the Australasian Faculty of Public Health Medicine (AFPHM). He is also a member of the Faculty of Travel Medicine.

Joe Baini was appointed Chief Executive Officer of the Australian Genome Research Facility in 2021. 

Mr Baini has more than three decades of experience holding senior management positions in large-scale biotechnology and pharmaceutical companies. With skills in strategic and market development, he has achieved success as the CEO of multinational, ASX-listed organisations since 2011.

Previously Mr Baini led the establishment of Gilead Sciences across Asia Pacific and built the fledgling organisation into a significant player in the pharmaceutical sphere. Prior to joining AGRF as Interim CEO earlier this year, Mr Baini worked as CEO of Immuron and PresSura Neuro and has been Principal of Exec Factor since 2008.

Professor Jason Payne is Chief Executive of Peter MacCallum Cancer Centre and a health professional with more than 28 years of clinical, management and leadership experience. Jason has been a champion for staff wellbeing throughout his career, with a strong belief that people perform at their best when they feel supported at work.

Jason has a wealth of operational experience and has overseen the expansion of multiple health services. He began his career as a nurse in 1994 at Austin Health where he worked for over a decade. In 2010, Jason became the Divisional Director, Cancer and Neurosciences at the Olivia Newton-John Cancer, Wellness & Research Centre. He has since then served in a series of executive roles including Chief Operating Officer and then Chief Executive of Mercy Health Services.

Adam Horsburgh was appointed Chief Executive Officer in June 2020. 

Adam joins Austin Health with extensive health sector management experience in Victoria, as well as in the UK National Health Service (NHS).

He has held senior policy and advisory roles with the Victorian Government’s Department of Health and Human Services (DHHS) and the Department of Premier and Cabinet.

Prior to joining Austin Health, Adam was Deputy Chief Executive Officer and Chief Operating Officer at Melbourne Health.

Dr Angus Henderson is General Manager, Research Strategy at Monash Health. Angus has completed post-doctoral fellowships at both Harvard Medical School, and the Australian National University. He holds a PhD in Medical Sciences from the John Curtin School of Medical Research; undergraduate degrees in medical science from the University of Sydney and the University of New South Wales.

Angus has also held senior positions with the Australian Government, including policy roles in innovation, biotechnology; global science projects, and international science and technology relations.

Cate is a technical advisor to Melbourne Genomics Health Alliance. She is an experienced healthcare executive and has worked in leadership roles in multiple academic, tertiary health services including The Royal Melbourne Hospital, The Alfred Hospital and Monash Health. Through these roles, Cate has deep experience in delivering high quality health care, achieving major improvements in health care and strengthening hospitals clinical leadership, clinical governance and research governance.

Alongside her work with Melbourne Genomics, Cate is currently working with the Fiji Ministry of Health and Medical Services to achieve improvements in clinical governance and clinical leadership at both a national and hospital level, as well as with the World Health Organisation to develop a program to train hospital leaders in clinical governance, antimicrobial stewardship and clinical leadership. She is also a non-executive director on the Board of Yooralla, a large disability services provider and is chair of the Service Development and quality committee.

Dr Kortnye Smith is a Medical Oncologist based at the Peter MacCallum Cancer Centre. She began her medical studies in Adelaide, before moving to Melbourne to pursue further training in medical oncology.

Kortnye has published and presented in the areas of genomic medicine, melanoma, and supportive care in cancer patients. She is committed to providing the best individualized and evidence-based care to her patients.

Norelle is an Infectious Diseases Physician & Clinical Microbiologist, co-appointed at Austin Health and The Peter Doherty Institute Microbiological Diagnostic Unit Public Health Laboratory.

She studied medicine at Monash University, completed physician training at the Alfred Hospital, and went on to specialise in infectious diseases and clinical microbiology before moving into research as a PhD student at University of Melbourne. Her time is now split between research - including the Controlling Superbugs project - and clinical work in infectious diseases at Austin Health. Norelle's research interests include antimicrobial (antibiotic) resistance and translating genomics into clinical and public health practice.

Dr Kushani Jayasinghe is a consultant nephrologist based at Monash Health whilst also undertaking dual training in clinical genetics at Royal Melbourne Hospital. Dr Jayasinghe studied Medicine at Monash University and undertook her physician training in Melbourne. She has a special interest in genetic kidney disease and is the clinical lead for genetic kidney disease at Monash Health. She completed her PhD research at Monash University on the clinical utility and feasibility of genomic sequencing in kidney disease. Her current research continues to focus on the clinical application of genomics in nephrology and improving the diagnostic yield of genomic sequencing in kidney disease through the application of the latest sequencing technologies in undiagnosed patients. Dr Jayasinghe is passionate about improving implementation of genomic medicine in routine nephrology care, which is a focus of her postdoctoral research at Monash University.

Dr Aamira Huq is a consultant clinical geneticist at The Royal Melbourne Hospital. She consults in neurogenetics, general genetics as well as familial cancer clinics. Aamira completed her PhD in 2019 through the University of Melbourne, supported by the Yulgilbar Alzheimer Research program and the Commonwealth Research Training Program Scholarships. Through her PhD, she explored various genomic aspects of dementia, including clinically oriented whole genome sequencing in dementia, as well as the utility of polygenic risk scores.

Prof Paul James is a Clinical Geneticist from Melbourne. He is the Director of the Parkville Familial Cancer Centre at the Royal Melbourne Hospital and Peter MacCallum Cancer Centre, and Head of Clinical Genetics in the Department of Genomic Medicine (RMH). He is the group leader of Familial Cancer Research at Peter MacCallum and leads a program of research involving familial disorders with a focus on translational studies that examine integration of genomic findings into clinical practice.